Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Knight

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|July 22, 2022
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy RecipientsJennifer M Knight, Mallory R Taylor, Kelly E Rentscher, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Translational Psychiatry|January 19, 2021
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically illJennifer M Knight, Erin S Costanzo, Suraj Singh, et al.
Journal of Clinical Epidemiology|March 18, 2015
Birth weight and maternal socioeconomic circumstances were inversely related to systolic blood pressure among Afro-Caribbean young adultsTrevor S Ferguson, Novie O Younger-Coleman, Marshall K Tulloch-Reid, et al.
The Journal of Pathology|October 17, 2022
Targeting the β<sub>2</sub> -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolismHatice Satilmis, Emma Verheye, Philip Vlummens, et al.
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
BMC Cancer|May 26, 2018
Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantationJennifer M Knight, Stephanie A Kerswill, Parameswaran Hari, et al.
Transplantation and Cellular Therapy|October 6, 2024
A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host DiseaseSheila Lahijani, Maria Rueda-Lara, Natalie McAndrew, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|July 22, 2022
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy RecipientsJennifer M Knight, Mallory R Taylor, Kelly E Rentscher, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Translational Psychiatry|January 19, 2021
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically illJennifer M Knight, Erin S Costanzo, Suraj Singh, et al.
Journal of Clinical Epidemiology|March 18, 2015
Birth weight and maternal socioeconomic circumstances were inversely related to systolic blood pressure among Afro-Caribbean young adultsTrevor S Ferguson, Novie O Younger-Coleman, Marshall K Tulloch-Reid, et al.
The Journal of Pathology|October 17, 2022
Targeting the β<sub>2</sub> -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolismHatice Satilmis, Emma Verheye, Philip Vlummens, et al.
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
BMC Cancer|May 26, 2018
Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantationJennifer M Knight, Stephanie A Kerswill, Parameswaran Hari, et al.
Transplantation and Cellular Therapy|October 6, 2024
A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host DiseaseSheila Lahijani, Maria Rueda-Lara, Natalie McAndrew, et al.
Pageof 10